A growing number of people with stage 4 cancer are experiencing the power of this new medication. “It does provide options ...

A new experimental drug, Daraxonrasib, is being used to help a local patient with pancreatic cancer at Memorial Regional ...

SEATTLE — Pancreatic cancer is considered one of the deadliest cancers, with a five-year survival rate of just 13 percent, by some estimates. But a promising new treatment in pill form is transforming ...

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

Colombia and DR Congo meet for the first time in history on Tuesday, with a win potentially putting either side on the brink of the World Cup knockout stages. For Colombia, that is the expectation.

An investigational targeted therapy designed to block one of the most common genetic drivers of pancreatic cancer has shown ...

Revolution Medicines has spent nearly a decade chasing what Dr. Alan Sandler, the Chief Development Officer at the company, calls a once-undruggable target – the elusive RAS gene, which is found in ...

Lynch syndrome, an autosomal dominant disorder caused by defective DNA mismatch repair genes, is linked to early-onset colorectal, ovarian, gastric, urinary tract and, less commonly, small bowel, ...

Pancreatic ductal adenocarcinoma is a common malignancy of the gastrointestinal tract. The number of new cases diagnosed and the number of deaths each year are almost identical, demonstrating the ...

As life expectancy rises and surgery becomes safer, India’s oldest patients are increasingly choosing to be active and ...